These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10515100)

  • 1. Assessment of budesonide patch tests.
    Bjarnason B; Flosadóttir E; Fischer T
    Contact Dermatitis; 1999 Oct; 41(4):211-7. PubMed ID: 10515100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity at edges of corticosteroid patch tests may be an indicator of a strong positive test response.
    Bjarnason B; Flosadóttir E; Fischer T
    Dermatology; 1999; 199(2):130-4. PubMed ID: 10559578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patch testing with neomycin sulfate.
    Bjarnason B; Flosadóttir E
    Contact Dermatitis; 2000 Nov; 43(5):295-302. PubMed ID: 11016671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objective non-invasive assessment of patch tests with the laser Doppler perfusion scanning technique.
    Bjarnason B; Flosadóttir E; Fischer T
    Contact Dermatitis; 1999 May; 40(5):251-60. PubMed ID: 10344480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time.
    Isaksson M; Bruze M; Goossens A; Lepoittevin JP
    Contact Dermatitis; 1999 Jan; 40(1):24-31. PubMed ID: 9928801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dark test-substance pigmentation on skin perfusion assessments and effect of test technique on balsam of Peru patch-test results.
    Bjarnason B; Flosadóttir E; Fischer T
    Contact Dermatitis; 2000 Jun; 42(6):318-25. PubMed ID: 10871094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of balsam of Peru patch tests.
    Bjarnason B; Flosadóttir E; Fischer T
    Contact Dermatitis; 2000 Jun; 42(6):326-9. PubMed ID: 10871095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of test techniques of perfusion of neomycin sulfate patch tests. A comparative study with visual assessments.
    Bjarnason B; Flosadóttir E
    Contact Dermatitis; 2000 Nov; 43(5):283-94. PubMed ID: 11016670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late patch-test reactions to budesonide need not be a sign of sensitization induced by the test procedure.
    Isaksson M; Bruze M
    Am J Contact Dermat; 2003 Sep; 14(3):154-6. PubMed ID: 14744407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective assessment of nickel sulfate patch test reactions with laser Doppler perfusion imaging.
    Bjarnason B; Fischer T
    Contact Dermatitis; 1998 Sep; 39(3):112-8. PubMed ID: 9771983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual and laser Doppler perfusion scanning assessments of Kathon CG patch test reactions.
    Bjarnason B; Fischer T
    Am J Contact Dermat; 1998 Dec; 9(4):224-30. PubMed ID: 9810023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018-2019.
    Stingeni L; Marietti R; Bianchi L; Guarneri F; Ferrucci SM; Faraci AG; Foti C; Romita P; Patruno C; Napolitano M; Gallo R; Corazza M; Schena D; Milanesi N; Bruni F; Pigatto P; Musumeci ML; Martina E; Piras V; Tramontana M; Hansel K
    Contact Dermatitis; 2021 Sep; 85(3):317-323. PubMed ID: 33931866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patch testing with budesonide.
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1998 Jul; 39(1):52-3. PubMed ID: 9686997
    [No Abstract]   [Full Text] [Related]  

  • 14. Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Camarasa JG; Diepgen T; Ducombs G; Frosch PJ; Goossens A; Lahti A; Menné T; Rycroft RJ; Seidenari S; Shaw S; Tosti A; Wahlberg J; White IR; Wilkinson JD
    Contact Dermatitis; 2000 Jan; 42(1):27-35. PubMed ID: 10644022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of patch-test application tape on reactions to sodium dodecyl sulfate.
    Fischer T; Dahlén A; Bjarnason B
    Contact Dermatitis; 1999 Jan; 40(1):32-7. PubMed ID: 9928802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact hypersensitivity to epoxy resin, methyldibromoglutaronitrile, tixocortol pivalate and budesonide in Hungary: a study in 1448 patients.
    Pónyai G; Németh I; Husz S; Jurcsik A; Nebenführer L; Dinnyés M; Némethy P; Kohánka V; Temesvári E
    G Ital Dermatol Venereol; 2011 Feb; 146(1):53-6. PubMed ID: 21317857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patch testing to detect corticosteroid allergy: is it adequate?
    Seukeran DC; Wilkinson SM; Beck MH
    Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patch testing with budesonide in serial dilutions. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Diepgen T; Ducomb G; Frosch PJ; Goossens A; Lahti A; Menné T; Seidenari S; Tosti A; Wahlberg J; Wilkinson JD
    Contact Dermatitis; 2000 Jun; 42(6):352-4. PubMed ID: 10871102
    [No Abstract]   [Full Text] [Related]  

  • 19. Allergic contact dermatitis from iodine preparations: a conundrum.
    Lee SK; Zhai H; Maibach HI
    Contact Dermatitis; 2005 Apr; 52(4):184-7. PubMed ID: 15859989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive usage testing with budesonide in experimental nickel--allergic contact dermatitis in individuals hypersensitive to budesonide.
    Isaksson M; Bruze M
    Br J Dermatol; 2001 Jul; 145(1):38-44. PubMed ID: 11453905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.